Aliases & Classifications for Teratoma

MalaCards integrated aliases for Teratoma:

Name: Teratoma 12 72 28 51 41 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:3307
MeSH 41 D013724
NCIt 46 C3403
UMLS 69 C0039538

Summaries for Teratoma

Disease Ontology : 12 A germ cell and embryonal cancer that is an encapsulated tumor with tissue or organ components resembling normal derivatives of all three germ layers.

MalaCards based summary : Teratoma is related to sacrococcygeal teratoma and mature teratoma. An important gene associated with Teratoma is AFP (Alpha Fetoprotein), and among its related pathways/superpathways are Wnt / Hedgehog / Notch and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Carboplatin and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include ovary, testis and bone, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 72 A teratoma is a tumor made up of several different types of tissue, such as hair, muscle, or bone. They... more...

Related Diseases for Teratoma

Diseases in the Teratoma family:

Malignant Teratoma Adult Teratoma
Intermediate Malignant Teratoma

Diseases related to Teratoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 654)
# Related Disease Score Top Affiliating Genes
1 sacrococcygeal teratoma 34.3 AFP CGA MNX1
2 mature teratoma 33.7 AFP POU5F1 TP53
3 central nervous system teratoma 33.6 GFAP SOX2
4 mature teratoma of the ovary 33.5 ENO2 KRT20
5 ovarian germ cell teratoma 33.5 KRT7 NKX2-1
6 ovarian cystic teratoma 33.3 KRT20 KRT7 NKX2-1
7 testicular germ cell tumor 33.2 AFP DMRT1 KIT TP53
8 malignant teratoma 32.8 AFP ENO2 NKX2-1 POU5F1 SYP
9 endodermal sinus tumor 32.7 AFP CGB3 KRT7
10 polyembryoma 32.7 AFP CGA
11 dermoid cyst 32.3 KIT KRT20 KRT7 MNX1
12 cystic teratoma 31.8 CDX2 ENO2 GFAP KRT20 KRT7 NKX2-1
13 mixed germ cell tumor 30.5 AFP CGA CGB3 KIT
14 testicular cancer 30.3 AFP CGA CGB3
15 cystadenoma 30.3 KRT20 KRT7 SYP
16 pseudomyxoma peritonei 30.2 CDX2 KRT20 KRT7 TP53
17 testicular seminoma 30.2 CGA CGB3
18 intestinal obstruction 30.2 CDX2 KRT20 KRT7
19 ovarian germ cell cancer 30.0 AFP KRT7 NKX2-1
20 oligodendroglioma 29.9 ENO2 GFAP SYP TP53
21 embryonal carcinoma 29.9 AFP KIT POU5F1 SOX2
22 ganglioneuroma 29.9 ENO2 GFAP SYP
23 clear cell adenocarcinoma 29.9 KRT20 KRT7 TP53
24 papilloma of choroid plexus 29.9 GFAP SYP TP53
25 embryonal testis carcinoma 29.9 AFP POU5F1
26 ovarian mucinous adenocarcinoma 29.8 CDX2 KRT20 KRT7
27 mucinous adenocarcinoma 29.8 CDX2 KRT20 KRT7 NKX2-1 TP53
28 adenocarcinoma in situ 29.8 CDX2 KRT20 KRT7
29 ovarian carcinosarcoma 29.8 ENO2 SYP
30 papillary carcinoma 29.8 KRT20 KRT7 NKX2-1
31 ovarian large-cell neuroendocrine carcinoma 29.7 KRT20 KRT7 SYP
32 seminoma 29.6 AFP CGA CGB3 ENO2 KIT POU5F1
33 ovarian embryonal carcinoma 29.6 AFP POU5F1 SOX2
34 central neurocytoma 29.6 ENO2 GFAP SYP
35 blastoma 29.5 NKX2-1 SYP TP53
36 endocervical adenocarcinoma 29.5 CDX2 KRT20 KRT7 TP53
37 hydrocephalus 29.4 ENO2 GFAP SYP TP53
38 central nervous system primitive neuroectodermal neoplasm 29.2 ENO2 GFAP SYP TP53
39 medullomyoblastoma 29.2 ENO2 GFAP SYP TP53
40 goblet cell carcinoid 29.2 ENO2 KRT20
41 renal cell carcinoma, nonpapillary 29.1 ENO2 KIT KRT20 KRT7 NKX2-1
42 leiomyosarcoma 29.1 ACTC1 ENO2 KIT TP53
43 neuroendocrine tumor 29.1 ENO2 KRT20 KRT7 NKX2-1 SYP
44 gliosarcoma 29.1 ACTC1 ENO2 GFAP TP53
45 medulloblastoma 29.0 ENO2 GFAP SYP TP53
46 glomus tumor 29.0 ACTC1 ENO2 SYP TP53
47 large cell neuroendocrine carcinoma 28.7 ENO2 KIT KRT20 KRT7 NKX2-1 SYP
48 small cell carcinoma 28.6 ENO2 KIT KRT20 KRT7 NKX2-1 SYP
49 horseshoe kidney 28.5 ACTC1 CDX2 ENO2 KRT20 KRT7 NKX2-1
50 growing teratoma syndrome 12.3

Graphical network of the top 20 diseases related to Teratoma:



Diseases related to Teratoma

Symptoms & Phenotypes for Teratoma

GenomeRNAi Phenotypes related to Teratoma according to GeneCards Suite gene sharing:

25 (show all 11)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-114 9.47 AFP
2 Increased shRNA abundance (Z-score > 2) GR00366-A-120 9.47 AFP
3 Increased shRNA abundance (Z-score > 2) GR00366-A-123 9.47 POU5F1
4 Increased shRNA abundance (Z-score > 2) GR00366-A-127 9.47 POU5F1
5 Increased shRNA abundance (Z-score > 2) GR00366-A-135 9.47 KRT7
6 Increased shRNA abundance (Z-score > 2) GR00366-A-149 9.47 POU5F1
7 Increased shRNA abundance (Z-score > 2) GR00366-A-192 9.47 AFP KRT7 POU5F1
8 Increased shRNA abundance (Z-score > 2) GR00366-A-29 9.47 AFP
9 Increased shRNA abundance (Z-score > 2) GR00366-A-32 9.47 POU5F1
10 Increased shRNA abundance (Z-score > 2) GR00366-A-63 9.47 AFP
11 Increased shRNA abundance (Z-score > 2) GR00366-A-74 9.47 KRT7 POU5F1

MGI Mouse Phenotypes related to Teratoma:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.18 TP53 ACTC1 CDX2 ENO2 GFAP GRN
2 behavior/neurological MP:0005386 10.17 AFP ENO2 GFAP GRN KIT MNX1
3 homeostasis/metabolism MP:0005376 10.03 ACTC1 AFP CDX2 CGA GFAP GRN
4 endocrine/exocrine gland MP:0005379 10.02 AFP CDX2 CGA DMRT1 KIT MNX1
5 digestive/alimentary MP:0005381 9.97 CDX2 GFAP KIT MNX1 NKX2-1 POU5F1
6 nervous system MP:0003631 9.9 CGA ENO2 GFAP GRN KIT MNX1
7 normal MP:0002873 9.65 GFAP KIT MNX1 NKX2-1 POU5F1 SOX2
8 reproductive system MP:0005389 9.32 AFP CDX2 CGA DMRT1 GRN KIT

Drugs & Therapeutics for Teratoma

Drugs for Teratoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 165)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 41575-94-4 10339178 38904 498142
2
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
3
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1 33419-42-0 36462
4
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1 3778-73-2 3690
5
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 51-75-2 4033
6 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1
7 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1
8 Etoposide phosphate Phase 4,Phase 3,Phase 2,Phase 1
9 Isophosphamide mustard Phase 4,Phase 3,Phase 2,Phase 1 0
10 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
11
Bleomycin Approved, Investigational Phase 3,Phase 2 11056-06-7 5360373
12
Oxaliplatin Approved, Investigational Phase 3,Phase 2,Phase 1 61825-94-3 43805 6857599 5310940 9887054
13
Paclitaxel Approved, Vet_approved Phase 3,Phase 2,Phase 1 33069-62-4 36314
14
Lenograstim Approved, Investigational Phase 2, Phase 3, Phase 1 135968-09-1
15
Vinblastine Approved Phase 3 865-21-4 241903 13342
16
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
17
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
18
Mesna Approved, Investigational Phase 3,Phase 1,Phase 2 3375-50-6 598
19
Captopril Approved Phase 3 62571-86-2 44093
20
Palivizumab Approved, Investigational Phase 3 188039-54-5
21
Ribavirin Approved Phase 3 36791-04-5 37542
22
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
23
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
24
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
25
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
26
Caspofungin Approved Phase 3 162808-62-0, 179463-17-3 2826718 468682
27
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
28
Ondansetron Approved Phase 3 99614-02-5 4595
29
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
30
Diphenhydramine Approved, Investigational Phase 3 58-73-1, 147-24-0 3100
31
Promethazine Approved, Investigational Phase 3 60-87-7 4927
32 Albumin-Bound Paclitaxel Phase 3,Phase 2,Phase 1
33 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
34 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
35 Antimitotic Agents Phase 3,Phase 2,Phase 1
36 Antirheumatic Agents Phase 3,Phase 2,Phase 1
37 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
38 Anti-Infective Agents Phase 3,Phase 1,Phase 2
39 Antimetabolites Phase 3,Phase 1,Phase 2
40 Antiviral Agents Phase 3,Phase 1,Phase 2
41 Hormone Antagonists Phase 3,Phase 2,Phase 1
42 Hormones Phase 3,Phase 2,Phase 1
43 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
44 Liver Extracts Phase 3,Phase 2,Phase 1
45 Antiemetics Phase 3,Phase 2,Phase 1
46 Autonomic Agents Phase 3,Phase 2,Phase 1
47 BB 1101 Phase 3,Phase 2,Phase 1
48 Dexamethasone acetate Phase 3,Phase 2,Phase 1 1177-87-3
49 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
50 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 100)

# Name Status NCT ID Phase Drugs
1 Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors Recruiting NCT01424839 Phase 4 Carboplatin, Etoposide, Ifosfamide;Cisplatin, etoposide, Ifosfamide (standard);Cisplatin, Etoposide, Ifosfamide (high dose)
2 Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Unknown status NCT00104676 Phase 3 cisplatin;etoposide;ifosfamide;oxaliplatin;paclitaxel
3 Combination Chemotherapy in Treating Men With Germ Cell Cancer Unknown status NCT00003643 Phase 2, Phase 3 cisplatin;etoposide;paclitaxel
4 Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy Unknown status NCT02097446 Phase 3
5 Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors Unknown status NCT00274950 Phase 3 carboplatin;cisplatin;etoposide;ifosfamide;vinblastine sulfate
6 Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors Completed NCT00053352 Phase 3 cisplatin;etoposide
7 Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors Completed NCT00002596 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide
8 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
9 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
10 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
11 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
12 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
13 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer Completed NCT00003941 Phase 3 cisplatin;etoposide;ifosfamide
14 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Completed NCT00716976 Phase 3 sodium thiosulfate
15 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
16 Single-port LC Might be Preferable for Managing Ovarian Dermoid Cyst. Completed NCT02009228 Phase 3
17 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3 Bleomycin;Carboplatin;Cisplatin;Etoposide
18 Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Recruiting NCT02375204 Phase 3 paclitaxel;ifosfamide;cisplatin;pegylated G-CSF;G-CSF;carboplatin;etoposide phosphate
19 Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Active, not recruiting NCT00085202 Phase 3 cisplatin;cyclophosphamide;vincristine
20 Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors Terminated NCT00072215 Phase 3 cisplatin;ifosfamide;paclitaxel;vinblastine
21 High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy Unknown status NCT01172912 Phase 2 carboplatin;cisplatin;dexamethasone;etoposide;ifosfamide
22 Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors Unknown status NCT00551122 Phase 1, Phase 2 cisplatin;gemcitabine hydrochloride;ifosfamide;paclitaxel
23 Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors Completed NCT00453232 Phase 2 cisplatin;etoposide
24 Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors Completed NCT00301782 Phase 2 carboplatin;cisplatin;etoposide phosphate;vincristine sulfate
25 Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment Completed NCT00453310 Phase 2 sunitinib malate
26 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Completed NCT00470366 Phase 2 cisplatin;ifosfamide;paclitaxel
27 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer Completed NCT00002931 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel
28 Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin Completed NCT00423852 Phase 1, Phase 2 carboplatin;ifosfamide;paclitaxel
29 Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment Completed NCT00091182 Phase 2 oxaliplatin
30 Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors Completed NCT00002489 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;leucovorin calcium;methotrexate;vincristine sulfate
31 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
32 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
33 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
34 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
35 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
36 Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors Completed NCT00070096 Phase 2 ixabepilone
37 Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer Completed NCT00004077 Phase 2 cisplatin;ifosfamide;paclitaxel
38 Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors Completed NCT00047320 Phase 2 carboplatin;etoposide;ifosfamide;thiotepa
39 Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors Completed NCT00002472 Phase 2 cisplatin;etoposide
40 Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors Completed NCT00003811 Phase 2 amifostine trihydrate;cisplatin;etoposide
41 High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors Completed NCT00003173 Phase 2 thiotepa
42 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors Completed NCT00024258 Phase 2 arsenic trioxide
43 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors Completed NCT00005955 Phase 2 temozolomide
44 Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Completed NCT00047177 Phase 2 Oxaliplatin
45 Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Recruiting NCT00432094 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel;thiotepa;Mesna
46 Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy Recruiting NCT02317393 Phase 2
47 PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER Recruiting NCT01037790 Phase 2 PD-0332991
48 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
49 Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors Recruiting NCT02114229 Phase 2 alisertib;methotrexate;cisplatin;carboplatin;cyclophosphamide;etoposide;topotecan;vincristine
50 Role of Axumin PET Scan in Germ Cell Tumor Recruiting NCT03426865 Phase 2 Axumin PET scan

Search NIH Clinical Center for Teratoma

Cochrane evidence based reviews: teratoma

Genetic Tests for Teratoma

Genetic tests related to Teratoma:

# Genetic test Affiliating Genes
1 Teratoma 28

Anatomical Context for Teratoma

MalaCards organs/tissues related to Teratoma:

38
Ovary, Testis, Bone, Thyroid, Brain, Bone Marrow, Liver

Publications for Teratoma

Articles related to Teratoma:

(show top 50) (show all 2522)
# Title Authors Year
1
Surgical management for a huge presacral teratoma and a meningocele in an adult with Currarino triad: a case report. ( 29352751 )
2018
2
Curious case of a black pleural effusion: Mediastinal teratoma presenting as massive pleural effusion. ( 29319045 )
2018
3
High-dose Chemotherapy is Efficacious and Well Tolerated in a Toddler With Aicardi Syndrome and Malignant Sacrococcygeal Teratoma. ( 29420371 )
2018
4
Antenatal Prediction of Neonatal Survival in Sacrococcygeal Teratoma. ( 29399854 )
2018
5
Teratoma as unusual cause of chest pain, hemoptysis and dyspnea in a young patient. ( 29321967 )
2018
6
Extraspinal sacrococcygeal ependymoma masquerading as sacrococcygeal teratoma in the pediatric patient. ( 29138922 )
2018
7
Failure to improve after ovarian resection could be a marker of recurrent ovarian teratoma in anti-NMDAR encephalitis: a case report. ( 29403279 )
2018
8
Bilateral ovarian angiosarcoma arising from the mature cystic teratomas - A case report and review of the literature. ( 29227858 )
2018
9
Surgical treatment of a type IV cystic sacrococcygeal teratoma with intraspinal extension utilizing a posterior-anterior-posterior approach: a case report. ( 29368306 )
2018
10
Teratoma Arising from Hepato Duodenal Ligament in the Newborn with Transection of Portal Vein, Hepatic Artery and Common Bile Duct: A Surgical Challenge. ( 29386766 )
2018
11
Radiological-pathological correlation of malignant teratoma with liposarcomatous transformation: Proven by repeated transthoracic needle biopsy. ( 29106050 )
2018
12
Chondroid nodule in the female peritoneum arises from normal tissue and not from teratoma or conception product. ( 29368082 )
2018
13
Early treatment of intrapericardial teratoma: a case presentation and systematic literature review. ( 29320914 )
2018
14
Dnd1-mediated epigenetic control of teratoma formation in mouse. ( 29378702 )
2018
15
Nephroblastoma Arising in a Primary Testicular Teratoma in a Nonatrophic Testis of a 50-Year-Old Man. ( 29309092 )
2018
16
Laparoscopic Excision of a Uterine Adenomatoid Tumor and a Coexisting Ovarian Teratoma: A Case Report and Literature Review. ( 28724848 )
2017
17
Mature cystic teratoma with high proportion of solid thyroid tissue: a controversial case with unusual imaging findings. ( 29299099 )
2017
18
Tumor markers and mature cystic teratoma of the ovary. ( 28882729 )
2017
19
Adrenal Teratoma: a Case Series and Review of the Literature. ( 28091891 )
2017
20
Giant Epignathus Teratoma Discovered at Birth: A Case Report and 7-Year Follow-Up. ( 28492758 )
2017
21
Case Report: Low-Grade Astrocytoma Within A Mature Cystic Teratoma In An Adolescent Patient. ( 29107097 )
2017
22
Early Delivery of Sacrococcygeal Teratoma with Intraspinal Extension. ( 28463844 )
2017
23
Split liver transplantation for retroperitoneal immature teratoma masquerading as hepatoblastoma. ( 28714114 )
2017
24
De Novo Tumors of Teratoma: Ganglioneuroma Arising From a Mature Cystic Teratoma of the Ovary. ( 28700440 )
2017
25
Intradural sacral mature teratoma associated with a low-lying conus. ( 28084287 )
2017
26
Risk factors for perioperative mortality and transfusion in sacrococcygeal teratoma resections. ( 28321971 )
2017
27
Growing Teratoma Syndrome Following Treatment for Immature Teratoma of Ovary-A Case Report and Review of Literature. ( 28706371 )
2017
28
Mucinous tumor arising in a giant sacrococcygeal teratoma: A rare case report. ( 29381973 )
2017
29
Laparoscopic excision of rare case of recurrent presacral teratoma. ( 28872101 )
2017
30
Mature teratoma of the uterine corpus: A case report. ( 28597671 )
2017
31
Mature Ovarian Teratoma After Treatment for Unilateral Retinoblastoma With Nonmutated RB1. ( 28719514 )
2017
32
Malignant Transformation of Mature Cystic Teratoma Diagnosed after a 10-Year Interval. ( 28607781 )
2017
33
Age-stratified analysis of tumor markers and tumor characteristics in adolescents and young women with mature cystic teratoma. ( 28826726 )
2017
34
Papillary Thyroid Microcarcinoma Arising Within a Mature Ovarian Teratoma: Case Report and Review of the Literature. ( 28615984 )
2017
35
Acromegaly and Cushing's syndrome caused by a neuroendocrine tumor arising within a sacrococcygeal teratoma. ( 29152267 )
2017
36
Ovarian teratoma: A case from 15th-18th century Lisbon, Portugal. ( 28888390 )
2017
37
Malignant transformation of a mature teratoma of the adrenal gland: A rare case report and literature review. ( 29137015 )
2017
38
Recurrent Masses after Testicular Cancer: Growing Teratoma Syndrome. A Case Report and Review of the Literature. ( 29279691 )
2017
39
Benign cystic mediastinal teratoma presenting as a massive pleural effusion in a 17-year-old boy. ( 28073871 )
2017
40
Sacrococcygeal teratoma: late recurrence warrants long-term surveillance. ( 28894920 )
2017
41
Malignant tumors associated with ovarian mature teratoma: A single institution experience. ( 28214217 )
2017
42
Endoscopic Resection of Skull Base Teratoma in Klippel-Feil Syndrome through Use of Combined Ultrasonic and Bipolar Diathermy Platforms. ( 28133560 )
2017
43
Giant sacrococcygeal teratoma: Management concerns with reporting of a rare occurrence of venous air embolism. ( 28217075 )
2017
44
Intracranial Teratoma: Imaging, Intraoperative, and Pathologic Features: AIRP Best Cases in Radiologic-Pathologic Correlation. ( 28898192 )
2017
45
Fetus in Fetu in Lieu of a Sacrococcygeal Teratoma: A Case Illuminating the Utility of Serial Prenatal Sonographic Examinations in Diagnosis. ( 28026891 )
2017
46
Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation. ( 28370831 )
2017
47
Agenesis of the dorsal pancreas associated with mucinous adenocarcinoma and cystic teratoma: a case report and literature review. ( 28174646 )
2017
48
A Case of Unilateral Endometriosis Coexisting with Struma Ovarii in Bilateral Ovarian Teratoma. ( 29223697 )
2017
49
Mature Cystic Teratoma With an Element of Hepatocellular Carcinoma in Anterior Mediastinum: Magnetic Resonance-Pathologic Correlation. ( 28914742 )
2017
50
Growing Teratoma Syndrome. ( 28127182 )
2017

Variations for Teratoma

Expression for Teratoma

Search GEO for disease gene expression data for Teratoma.

Pathways for Teratoma

GO Terms for Teratoma

Biological processes related to Teratoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of transcription by RNA polymerase II GO:0000122 9.8 CDX2 DMRT1 NKX2-1 POU5F1 SOX2 TP53
2 positive regulation of gene expression GO:0010628 9.65 ACTC1 KIT NKX2-1 POU5F1 TP53
3 response to wounding GO:0009611 9.58 GFAP POU5F1 SOX2
4 regulation of transcription by RNA polymerase II GO:0006357 9.43 CDX2 CGA CGB3 KIT MNX1 NKX2-1
5 germ cell migration GO:0008354 9.37 DMRT1 KIT
6 endodermal cell fate specification GO:0001714 9.16 POU5F1 SOX2
7 somatic stem cell population maintenance GO:0035019 8.92 CDX2 KIT POU5F1 SOX2

Molecular functions related to Teratoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 DNA binding transcription factor activity GO:0003700 9.5 CDX2 DMRT1 MNX1 NKX2-1 POU5F1 SOX2
2 sequence-specific DNA binding GO:0043565 9.17 CDX2 DMRT1 MNX1 NKX2-1 POU5F1 SOX2

Sources for Teratoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....